Karima Mokhtari
Centre National de la Recherche Scientifique(FR)Inserm(FR)University of Isfahan(IR)Sorbonne Université(FR)Assistance Publique – Hôpitaux de Paris(FR)Institut de Myologie(FR)Pitié-Salpêtrière Hospital(FR)Institut du Cerveau(FR)The Ohio State University(US)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Brain Metastases and Treatment, CNS Lymphoma Diagnosis and Treatment, Meningioma and schwannoma management, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial(2009)7,709 cited
- → Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas(2009)998 cited
- → Radiotherapy for Glioblastoma in the Elderly(2007)780 cited
- → Mechanisms and therapeutic implications of hypermutation in gliomas(2020)685 cited
- → High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses(2012)685 cited
- → IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas(2010)529 cited